IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Q3 2018 Holdings

Filed 2018-11-14 | 6 holdings | $440.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$136.3K8,930,23730.9%
Solid Biosciences IncCOM83422E105$93.9K1,989,44421.3%
Aptinyx IncCOM03836N103$64.4K2,225,09214.6%
Inflarx NV(IFRX)COMN44821101$60.6K1,764,88813.7%
Replimune Group Inc(REPL)COM76029N106$45.7K2,838,96810.4%
Marinus Pharmaceuticals IncCOM56854Q101$39.8K3,977,4539.0%